New Owner
Bristol-Myers Squibb - Cardioxyl Pharmaceuticals
Bristol-Myers Squibb acquires Cardioxyl Pharmaceuticals
Announced: November 02, 2015
Type: Acquisition
Disposition: Separate Entity
Status: Complete
Amount: $ 2,000,000,000
Bristol-Myers Squibb Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Aug 03, 2017 |
|
Undisclosed amount |
| Jul 05, 2016 |
|
Undisclosed amount |
| Mar 23, 2016 |
|
$ 600,000,000 |
| Feb 23, 2015 |
|
$ 1,250,000,000 |
| Nov 04, 2014 |
|
$ 444,000,000 |
